Haemonetics reports Q1 FY2025 results; details in press release not provided

HAEMONETICS CORP

2025-Q1 EPS reported $0.74 revenue$336,172,000

Filed 8-K on August 8, 2024 for quarter ended June 29, 2024.
Press release attached as Exhibit 99.1 but text not included in this summary.
Specific financial figures (revenue, EPS) not available from given text.

item 2.02 item 9.01

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-24-000053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.